Altretamine
Term · Oncology and biomedicine · MLC-T-ONC-000421
An anticancer drug that belongs to the family of drugs called alkylating agents.
A synthetic cytotoxic s-triazine derivative similar in structure to alkylating agent triethylenemelamin with antineoplastic activity. Although the precise mechanism by which altretamine exerts its cytotoxic effect is unknown, N-demethylation of altretamine may produce reactive intermediates which covalently bind to DNA, resulting in DNA damage.
| Identifier | MLC-T-ONC-000421 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | HMM |
| Synonyms | hemel; hexaloids; hexamethylamine; hexamethylmelamine |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-000421",
"term": "Altretamine",
"field": "Oncology and biomedicine",
"definitions": [
"An anticancer drug that belongs to the family of drugs called alkylating agents.",
"A synthetic cytotoxic s-triazine derivative similar in structure to alkylating agent triethylenemelamin with antineoplastic activity. Although the precise mechanism by which altretamine exerts its cytotoxic effect is unknown, N-demethylation of altretamine may produce reactive intermediates which covalently bind to DNA, resulting in DNA damage."
],
"abbreviation": "HMM",
"synonyms": [
"hemel",
"hexaloids",
"hexamethylamine",
"hexamethylmelamine"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/altretamine/"
}
Record 910 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.